Publication of TiGenix’ results in the American Journal of Sports Medicine

Leuven (BELGIUM) - February 5, 2008 - TiGenix (EURONEXT: TIG), the biomedical company that focuses on innovative local treatments for damaged and osteoarthritic joints announces the publication of the ChondroCelect® TIG/ACT/01/2000 clinical study in a top-level orthopaedic journal.

The publication entitled: "Characterized chondrocyte implantation results in better structural repair when treating symptomatic cartilage defects of the knee in a randomized controlled trial versus microfracture" by D. Saris, J. Vanlauwe et al. appears as first article in the February issue of the American Journal of Sports Medicine, Vol. 36, No. 2, pp. 235-246 and is pre-published online since January 24. The American Journal of Sports Medicine is the official journal of the American Orthopaedic Society for Sports Medicine (AOSSM). It is one of the highest ranked, peer-reviewed orthopaedic and sport sciences journals.

More info on TiGenix' website or on the TiGenix press release